Skip to main content
BTC / USDTCRYPTO107,400+2.19%ETH / USDTCRYPTO3,840+2.13%SOL / USDTCRYPTO182.40−1.99%BNB / USDTCRYPTO652.30+0.66%XRP / USDTCRYPTO2.2150+1.61%DOGE / USDTCRYPTO0.3850−1.79%TON / USDTCRYPTO5.240+2.34%AVAX / USDTCRYPTO42.60−2.07%LINK / USDTCRYPTO22.40+2.28%ADA / USDTCRYPTO1.0520−1.68%TRX / USDTCRYPTO0.3300+0.92%DOT / USDTCRYPTO8.420+2.93%BTC / USDTCRYPTO107,400+2.19%ETH / USDTCRYPTO3,840+2.13%SOL / USDTCRYPTO182.40−1.99%BNB / USDTCRYPTO652.30+0.66%XRP / USDTCRYPTO2.2150+1.61%DOGE / USDTCRYPTO0.3850−1.79%TON / USDTCRYPTO5.240+2.34%AVAX / USDTCRYPTO42.60−2.07%LINK / USDTCRYPTO22.40+2.28%ADA / USDTCRYPTO1.0520−1.68%TRX / USDTCRYPTO0.3300+0.92%DOT / USDTCRYPTO8.420+2.93%
Fiyatlandırma
macroJul 11, 2026, 5:50 AM

Chinese Scientists Develop Intelligent System for Consistent Organoid Cultivation

A team from Harbin Institute of Technology and BGI Genomics has created an intelligent system that produces consistent 'blood island organoids', overcoming the randomness that has prevented clinical use.

Researchers from Harbin Institute of Technology and BGI Genomics have developed a smart system capable of growing uniform 'blood island organoids'. This breakthrough addresses the longstanding issue of variability in organoid production, which has hindered their application in clinical settings.

Previously, organoid cultivation involved significant guesswork, making it difficult to replicate results reliably. The new intelligent system aims to standardize the process, potentially enabling mass production of these biological structures for therapeutic and research purposes.

This advancement could accelerate the use of organoids in drug testing and regenerative medicine, though further validation and scaling are required.

Source: First Squawk